Evidence to date therefore suggests that further investigation into the complex molecular mechanisms of caspase-4 and -5 regulation, activation and signalling has the potential to provide new strategies for therapeutic intervention in inflammatory bowel diseases. Here, CASP4 is linked to inflammatory bowel disease.